NEUCA S.A. (WSE:NEU)

Market Cap	3.04B
Revenue (ttm)	13.04B
Net Income (ttm)	135.42M
Shares Out	4.48M
EPS (ttm)	29.76
PE Ratio	22.79
Forward PE	17.33
Dividend	16.00 (2.36%)
Ex-Dividend Date	Jul 15, 2025

Volume	650
Average Volume	1,096
Open	673.00
Previous Close	676.00
Day's Range	673.00 - 680.00
52-Week Range	636.00 - 900.00
Beta	0.57
RSI	45.98
Earnings Date	Nov 14, 2025

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company owns and produces Rx, OTC medicines, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brand names to pharmacists, medical doctors,...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1990
• Employees: 4,445
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NEU

Financial Performance

In 2024, NEUCA's revenue was 12.61 billion, an increase of 6.76% compared to the previous year's 11.81 billion. Earnings were 154.24 million, an increase of 5.45%.